Andreas Blum

1.6k total citations · 1 hit paper
29 papers, 1.0k citations indexed

About

Andreas Blum is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Organic Chemistry. According to data from OpenAlex, Andreas Blum has authored 29 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Organic Chemistry. Recurrent topics in Andreas Blum's work include Hormonal Regulation and Hypertension (8 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Andreas Blum is often cited by papers focused on Hormonal Regulation and Hypertension (8 papers), HIV/AIDS drug development and treatment (5 papers) and Pharmacological Effects of Natural Compounds (4 papers). Andreas Blum collaborates with scholars based in Germany, United Kingdom and United States. Andreas Blum's co-authors include Marcus Frings, Carsten Bolm, Christian Gnamm, Edmund Maser, Wibke E. Diederich, G. Klebe, Jark Böttcher, A. Heine, Jonathan A. Doorn and Hans-Jörg Martin and has published in prestigious journals such as Circulation, Journal of Molecular Biology and Biochemistry.

In The Last Decade

Andreas Blum

29 papers receiving 986 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sulfoximines from a Medicinal Chemist's Perspective: Physicochemical and in vitro Parameters Relevant for Drug Discovery

2016 397 citations Marcus Frings, Carsten Bolm et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Blum Germany	14	506	281	130	80	56	29	1.0k
Donatella Boschi Italy	21	466 0.9×	500 1.8×	65 0.5×	103 1.3×	32 0.6×	70	1.2k
Marco L. Lolli Italy	22	386 0.8×	563 2.0×	56 0.4×	143 1.8×	31 0.6×	67	1.2k
David P. Rotella United States	21	509 1.0×	702 2.5×	65 0.5×	37 0.5×	68 1.2×	57	1.3k
Hans Hilpert Switzerland	18	356 0.7×	426 1.5×	56 0.4×	39 0.5×	60 1.1×	36	1.1k
Patrizio Mattei Switzerland	16	201 0.4×	462 1.6×	135 1.0×	29 0.4×	60 1.1×	24	980
Shinya Fujii Japan	24	591 1.2×	619 2.2×	108 0.8×	40 0.5×	31 0.6×	106	1.7k
David G. Barrett United States	17	366 0.7×	483 1.7×	111 0.9×	35 0.4×	14 0.3×	50	1.0k
Prashant R. Murumkar India	22	633 1.3×	566 2.0×	37 0.3×	22 0.3×	35 0.6×	58	1.4k
Frederick Sweet United States	19	403 0.8×	481 1.7×	261 2.0×	191 2.4×	25 0.4×	64	1.1k
Steven Westwood France	16	378 0.7×	287 1.0×	67 0.5×	21 0.3×	19 0.3×	33	924

Countries citing papers authored by Andreas Blum

Since Specialization

Citations

This map shows the geographic impact of Andreas Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Blum more than expected).

Fields of papers citing papers by Andreas Blum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Blum. The network helps show where Andreas Blum may publish in the future.

Co-authorship network of co-authors of Andreas Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Blum. A scholar is included among the top collaborators of Andreas Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Blum. Andreas Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Esdar, Christina, Nina Linde, Andreas Blum, et al.. (2025). M4205 (IDRX-42) Is a Highly Selective and Potent Inhibitor of Relevant Oncogenic Driver and Resistance Variants of KIT in Cancer. Molecular Cancer Therapeutics. 24(7). 1040–1053. 1 indexed citations

Blum, Andreas, Dieter Dorsch, Nina Linde, et al.. (2023). Identification of M4205─A Highly Selective Inhibitor of KIT Mutations for Treatment of Unresectable Metastatic or Recurrent Gastrointestinal Stromal Tumors. Journal of Medicinal Chemistry. 66(4). 2386–2395. 8 indexed citations

Schröder, Martin, Ulrich Grädler, Juliane Braun, et al.. (2022). MSC-1186, a Highly Selective Pan-SRPK Inhibitor Based on an Exceptionally Decorated Benzimidazole-Pyrimidine Core. Journal of Medicinal Chemistry. 66(1). 837–854. 6 indexed citations

Frings, Marcus, Carsten Bolm, Andreas Blum, & Christian Gnamm. (2016). Sulfoximines from a Medicinal Chemist's Perspective: Physicochemical and in vitro Parameters Relevant for Drug Discovery. European Journal of Medicinal Chemistry. 126. 225–245. 397 indexed citations breakdown →

Blum, Andreas, et al.. (2011). Two Solutions for the Same Problem: Multiple Binding Modes of Pyrrolidine-Based HIV-1 Protease Inhibitors. Journal of Molecular Biology. 410(4). 745–755. 8 indexed citations

Jacques, Sylvain A., Andreas Blum, Nathalie Lebrasseur, et al.. (2011). Studies on the Total Synthesis of Lactonamycin: Synthesis of the Fused Pentacyclic B–F Ring Unit. European Journal of Organic Chemistry. 2012(1). 107–113. 8 indexed citations

Blum, Andreas, et al.. (2011). Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor. The Journal of Steroid Biochemistry and Molecular Biology. 128(1-2). 51–55. 32 indexed citations

Luksch, Torsten, et al.. (2010). Pyrrolidine Derivatives as Plasmepsin Inhibitors: Binding Mode Analysis Assisted by Molecular Dynamics Simulations of a Highly Flexible Protein. ChemMedChem. 5(3). 443–454. 12 indexed citations

Blum, Andreas, Angelo D. Favia, & Edmund Maser. (2008). 11β-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds. Molecular and Cellular Endocrinology. 301(1-2). 132–136. 20 indexed citations

10.

Böttcher, Jark, et al.. (2008). Targeting the Open‐Flap Conformation of HIV‐1 Protease with Pyrrolidine‐Based Inhibitors. ChemMedChem. 3(9). 1337–1344. 27 indexed citations

11.

Blum, Andreas, Jark Böttcher, Torsten Luksch, et al.. (2008). Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors. Bioorganic & Medicinal Chemistry. 16(18). 8574–8586. 11 indexed citations

12.

Böttcher, Jark, Andreas Blum, A. Heine, Wibke E. Diederich, & G. Klebe. (2008). Structural and Kinetic Analysis of Pyrrolidine-Based Inhibitors of the Drug-Resistant Ile84Val Mutant of HIV-1 Protease. Journal of Molecular Biology. 383(2). 347–357. 16 indexed citations

13.

Blum, Andreas & Edmund Maser. (2003). The critical role of the N-terminus of 11β-hydroxysteroid dehydrogenase type 1, as being encoded by exon 1, for enzyme stabilization and activity. Chemico-Biological Interactions. 143-144. 469–480. 5 indexed citations

14.

Blum, Andreas & Edmund Maser. (2003). Enzymology and Molecular Biology of Glucocorticoid Metabolism in Humans. Progress in nucleic acid research and molecular biology. 75. 173–216. 35 indexed citations

15.

Blum, Andreas, et al.. (2003). Functional Characterization of the Human 11β-Hydroxysteroid Dehydrogenase 1B (11β-HSD 1B) Variant. Biochemistry. 42(14). 4108–4117. 11 indexed citations

16.

Blum, Andreas, et al.. (2002). Isolation of an antifreeze peptide from the Antarctic sponge Homaxinella balfourensis. Cellular and Molecular Life Sciences. 59(12). 2210–2215. 10 indexed citations

17.

Blum, Andreas, et al.. (2001). Human 11β-hydroxysteroid dehydrogenase 1/carbonyl reductase: additional domains for membrane attachment?. Chemico-Biological Interactions. 130-132(1-3). 749–759. 9 indexed citations

18.

Xiong, Guangming, et al.. (2001). A model on the regulation of 3α-hydroxysteroid dehydrogenase/carbonyl reductase expression in Comamonas testosteroni. Chemico-Biological Interactions. 130-132(1-3). 723–736. 10 indexed citations

19.

Blum, Andreas, et al.. (2000). Human 11β-hydroxysteroid dehydrogenase 1/carbonyl reductase: recombinant expression in the yeast Pichia pastoris and Escherichia coli. Toxicology. 144(1-3). 113–120. 29 indexed citations

20.

Blum, Andreas, Hans-Jörg Martin, & Edmund Maser. (2000). Human 11β-Hydroxysteroid Dehydrogenase Type 1 Is Enzymatically Active in Its Nonglycosylated Form. Biochemical and Biophysical Research Communications. 276(2). 428–434. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact